"With steady progress towards elimination over the past two years, it is of particular concern that measles cases are climbing in Europe," the agency's regional director for Europe, Zsuzsanna Jakab, said in a statement.
"Today's travel patterns put no person or country beyond the reach of the measles virus," she said.
The respiratory disease, characterised by high fever and small red spots, usually triggers only mild symptoms, but it remains one of the leading causes of death among young children globally.
The virus is spread by coughing and sneezing, and by close contact with infected individuals.
Also Read
France, Germany, Italy, Romania, Poland, Switzerland and Ukraine were the most affected, accounting for 474 of the 559 cases reported for January.
In these countries, national vaccination levels against the virus are below the 95 per cent threshold considered necessary for protecting the entire population.
Preliminary figures for February indicate that the number of new infections is rising sharply, the WHO said.
The figures cover the agency's entire European region, covering 53 countries including Israel, Kazakhstan and Russia.
"Outbreaks will continue in Europe, as elsewhere, until every country reaches the level of immunisation needed to fully protect their populations," she added.
Currently, the largest outbreaks are occurring in Italy and Romania.
The number of measles cases in Italy has tripled this year, largely because parents are not getting children vaccinated because of fears of a link between the combined measles, mumps and rubella (MMR) vaccination shot and autism, the health ministry said last week.
In Romania, a measles outbreak has killed 17 children and infected thousands more since September, the result of both poverty and an anti-vaccination movement, local media reported Saturday.
In poor countries, many people do not have access to the USD 1 vaccine (94 euro cents), but the WHO has pointed out that children in affluent countries have a greater risk of infection because of scepticism about immunisation.
Disclaimer: No Business Standard Journalist was involved in creation of this content